Just like beans, peas and lentils are packed with protein and antioxidant compounds. Why don’t we eat more of them? While less commonly found in American dishes, lentils are a regular fixture in ...

Prelude Therapeutics Incorporated (Nasdaq: PRLD) showcased significant advancements in its oncology research at the American ...

Our pipeline is comprised of several novel drug candidates including first-in-class, highly selective SMARCA2 and KAT6A degraders, and ongoing research into other precision oncology targets. We are ...

Americans exhibit a notable obsession with protein, evident in their high consumption of supplements and protein-infused foods. This trend has fueled the growth of the protein powder market and ...

When a 32-year-old patient with protein deficiency came to meet Bhakti Samant, chief dietician at Kokilaben Dhirubhai Ambani Hospital, Mumbai, he had thought she would prescribe a protein supplement.

Preclinical data elucidating the mechanism of action of PRT3789, Prelude's first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude's efforts ...

² Prelude hypothesized that a targeted protein degradation approach could enable discovery of KAT6A selective candidates with potential for improved hematological safety and more robust single ...

April 25, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the presentation of new preclinical data at the ...

highly selective SMARCA2 and KAT6A degraders, and ongoing research into other precision oncology targets. We are also leveraging our expertise in targeted protein degradation to discover ...

2 Prelude hypothesized that a targeted protein degradation approach could enable discovery of KAT6A selective candidates with potential for improved hematological safety and more robust single ...